© 2 0 1 8 I n d I a n J o u r n a l o f P a t h o l o g y a n d M I c r o b I o l o g y | P u b l I s h e d b y W o l t e r s K l u W e r -M e d K n o W 101
INTRODUCTION
We present here a unique case of a 66-year-old female with adjoining Merkel cell carcinoma (MCC) and seborrheic keratosis (SK). MCC is lethal in 33% of cases. [1] MCC is frequently misdiagnosed during clinical presentation. An adjoining SK, as seen in the present case, can be a further misleading lesion as it has a contrasting clinical appearance. A common viral etiological agent, the Merkel cell polyomavirus (MCPyV), could suggest a cause and effect relationship in the future.
CASE REPORT
An elderly female presented with history of a mole in the epigastric region. She noticed a recent increase in its size over the past 15 days. The lesion was excised in toto and submitted for pathologic examination.
Gross examination revealed a single skin covered fibrofatty tissue measuring 3.5 cm × 3 cm × 2 cm, the center of which shows an elevated warty lesion measuring 1.5 cm.
Microscopically, the superficial portion revealed orthokeratosis, acanthosis, numerous horn cysts, and squamous eddies [ Figures 1 and 2 ]. A malignant tumor was seen in the adjoining superficial dermis -abutting and ironing out the overlying epidermis [ Figure 2 ]. The cells were arranged both diffusely and as infiltrating cords. The cells were small round having scanty to absent cytoplasm and coarsely stippled chromatin [ Figure 3 ]. Brisk mitotic activity was seen. There was no ulceration. Excision margins were clear.
Immunohistochemistry
• CK20, synaptophysin, and chromogranin showed strong positivity in tumor cells • CK7 and MIC-2 were negative • CK20 revealed characteristic dot-like paranuclear staining.
The diagnosis of MCC and SK was rendered.
DISCUSSION
MCC is a rare, highly aggressive skin cancer with rapidly increasing incidence since last few decades. The most significant features can be summarized in the acronym, "AEIOU:" [2] • Asymptomatic • Expanding rapidly • Immunosuppressed • Older than 50 years • UV-exposed skin site.
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in the USA alone. Local recurrence rate of 25%-44% (higher than melanoma), high regional lymph node spread of 10%-45%, and mortality rates of 72% at 2 years imply a need for aggressive multidisciplinary diagnostic and therapeutic management with the much acknowledged importance of sentinel lymph node biopsy.
MCPyV has been detected in over 80% of cases of MCC. In another study, MCPyV sequences were detected in 64% MCC and 16% SK. [3] MCPyV-associated transformation of Merkel cell to MCC involves (1) MCPyV DNA genomic integration and (2) large T antigen mutation. The T antigens of MCPyV are the most important proteins encoded by polyomavirus for their life within the cell. [4] Expression of oncogenic T antigen is mandatory for the survival and growth of MCPyV-positive MCC cell lines. [5] The incidence of Merkel cell hyperplasia and MCC in situ which are "benign" cytologically and with the CK20 staining pattern (uniform, lacking the perinuclear dot-like pattern) has been described thrice earlier in the literature, in cases of SK. [6] Speculation of a benign counterpart (Merkel cell epithelioma) in continuum with the same spectrum also gives further reference to a possible melanoma-like sequential evolution of Merkel cell lesions, potentially arising from the entrapped follicular epithelium (outer root sheath) within the epidermal slow adapting mechanoreceptor, "Haarsheibe."
MCC and SK as parts of the same lesion is a unique finding that has not been reported thus far, thus lending further credence to the purported common viral etiological association.
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